Aim of the virtual conference is to facilitate Indian Pharma Industry adopt Green & Sustainable Chemistry as a tool to enhance Economic & Environmental Competitiveness
Molnupiravir is an orally administered form of a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
2022 is going to be the year of opportunities and innovations from the medical industry in India
The company will provide recyclability services to brands with a final goal to help them move to fully recyclable packaging
The setting up of these 8 plants will lead to a total committed investment of Rs. 260.40 crore
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Subscribe To Our Newsletter & Stay Updated
